SHL makes debut at APLAR-ARA 2019
SHL Group will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress from 8-11 April in Brisbane, Australia. The congress will be held in conjunction with the Australian Rheumatology Association.
UCSF discover potential new treatment approach for type 1 diabetes
Researchers at the University of California, San Francisco (UCSF) Diabetes Centre have uncovered evidence to suggest assumptions about the cause of type 1 diabetes are incorrect, meaning existing approaches to finding new treatments for this type of diabetes have been misguided.
Greater Manchester backs move to outcome-based payment
The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and Europe